Parenteral Nutrition Market Scope And Analysis

  • Report Code : TIPRE00005217
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 154
Buy Now

Parenteral Nutrition Market Scope and Analysis by 2030

Buy Now


Parenteral Nutrition Market Report Scope

Report Attribute Details
Market size in 2022 US$ 6.84 Billion
Market Size by 2030 US$ 11.12 Billion
Global CAGR (2022 - 2030) 6.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Nutrient Type
  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements
  • Vitamins and Minerals
By End User
  • Hospitals
  • Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Sichuan Kelun Biotech Biopharmaceutical Co Ltd
  • Vifor Pharma Management AG
  • Parenteral Nutrition Market News and Recent Developments

    The Parenteral Nutrition Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the parenteral nutrition market are listed below:

    • Baxter International Inc. received U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) nutrition (PN) when oral or enteral nutrition is not possible, insufficient or contraindicated. Clinolipid has been available in the U.S. for adults since 2019 and is now available for use in all ages. (Source: Baxter International Inc., Company Website, January 2020)

    Parenteral Nutrition Market Report Coverage and Deliverables

    The “Parenteral Nutrition Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

    • Parenteral nutrition market  size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Parenteral nutrition market  trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Parenteral nutrition market  analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the parenteral nutrition market
    • Detailed company profiles